Good Morning, Traders!…👋

U.S. stocks fluctuated early Friday, on track to close out the week with losses as rising deficit concerns and surging Treasury yields continued to pressure sentiment. 

The market remains focused on the economic implications of President Trump’s sweeping tax-and-spending bill, which advanced in the House this week. Fears that the legislation could add trillions to the national deficit have fueled a spike in long-term Treasury yields.

The 30-year yield held above 5% on Friday—territory not seen since the financial crisis—amplifying concerns already stoked by Moody’s recent U.S. credit downgrade.

Earnings Watch

Earnings hit today from Toronto-Dominion Bank $TD ( ▲ 0.63% )  and Booz Allen $BAH ( ▼ 0.37% )  before open, with no major reports after close.

Analysts expect TD to post $1.97 EPS with banking strength and Booz Allen to hit $1.49 EPS on defense consulting growth—could these beats spark rallies?

Happening Today

✓ 08:30 AM ET – Building Permits (Apr)

✓ 10:00 AM ET – New Home Sales (Apr)

✓ 04:30 PM ET – CFTC Nasdaq 100 and S&P500 speculative net positions

PREMARKET SNAPSHOT 📈

U.S. equity futures are steady this morning as investors weigh concerns over rising national debt and elevated Treasury yields following the House's approval of President Trump's $3.8 trillion tax-and-spending bill. Despite these fiscal worries, the S&P 500 and Nasdaq remain on track for their best month of 2025, supported by easing tariffs and soft inflation data.

SECTOR SNAPSHOT✨

The market showed mixed performance yesterday, with modest gains in consumer discretionary, tech, and communication services offering some relief. However, most sectors, including health care, energy, and financials, slipped into the red. Utilities posted the steepest loss, while industrials remained flat on the day. Overall, market sentiment was cautious with only a few sectors managing to edge higher.

PreMarket Unusual Volume Stocks

📈 INNEOVA Holdings Limited $INEO is making waves pre-market with a 56% surge and volume of 5.85M—over 5,000% higher than its average. The move suggests strong speculative interest or early reaction to potential corporate news.

📈 Imunon, Inc. $IMNN is up over 10% in early trade on volume that has jumped nearly 4,500% above its norm. The biotech stock is drawing strong interest, possibly tied to pipeline updates or sector-wide momentum.

📈 VCI Global Limited $VCIG is seeing a pre-market gain of nearly 15%, with volume rising over 830% from its typical levels. The increased activity points to renewed attention from small-cap traders.

📈 PDS Biotechnology Corporation $PDSB is up nearly 10%, supported by volume 455% above average. Investors may be positioning ahead of data releases or capitalizing on value-driven plays in biotech.

📈 BloomZ Inc. $BLMZ is up 39% pre-market, with over 32M shares traded—more than double its average. The volume spike suggests strong retail momentum or reaction to a low-float setup.

Premarket Picks

BloomZ Inc. (BLMZ) is making headlines with a significant pre-market jump of 42.99%, trading at $0.19. The surge follows the announcement of a strategic business alliance with M-NEXT Holdings Co., Ltd., aimed at boosting affiliated talent development and driving increased store traffic.

SOBR Safe, Inc. (SOBR) saw its shares climb 15.41% in pre-market trading, reaching $3.37. The spike comes on the heels of the company's first quarter 2025 earnings report, which has evidently impressed investors.

VCI Global Limited (VCIG) is up 12.04% before market open, now priced at $3.35. The company recently revised its equity agreement to reflect a 102% premium, a move that enhances its strategic financial flexibility and appears to have resonated positively with the market.

NuScale Power Corporation (SMR) rose 17.89%, hitting $29.85 in pre-market activity. This gain follows the company's announcement of its new Energy Exploration (E2) Center™ at South Carolina State University, a project aimed at fostering the next generation of professionals in the nuclear energy sector.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. Charles River Laboratories International, Inc. (CRL)

Analyst Firm: Redburn Atlantic
Upgraded: Neutral to Buy
Price Target: $182
Yesterday's Close: $135.60

Redburn Atlantic has raised its rating on Charles River, moving it from Neutral to Buy, and set a new price target of $182.

Analysts have set a range of price targets for Charles River Laboratories, with estimates spanning from a low of $70.00 to a high of $188.00. The median target stands at $155.00, while the average comes in at $153.13. The company is known for providing essential products and services to pharmaceutical and biotech firms.

2. Waste Management, Inc. (WM)

Analyst Firm: JPMorgan
Upgraded: Neutral to Overweight
Price Target: $277
Yesterday's Close: $233.32

JPMorgan's analyst Tami Zakaria has upgraded WM from Neutral to Overweight, increasing the price target from $225 to $277.

For Waste Management, Inc., analyst projections place the stock price between $225.00 and $271.00, with both the median and average targets at $250.50. The company operates as a holding entity offering comprehensive environmental waste management services.

3. Wix.Com Ltd (WIX)

Analyst Firm: Baird
Upgraded: Neutral to Outperform
Price Target: $190
Yesterday's Close: $154.99

Baird has upgraded Wix.com to an Outperform rating from Neutral, assigning a new price target of $190.

Wix.com Ltd. has price targets ranging from $173.00 on the low end to $250.00 on the high end. Analysts cite a median estimate of $230.00 and an average target of $223.05. Wix is a leading provider of cloud-based web development platforms, offering tools for website creation, SEO, and marketing.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.